Skip to content

Clinical trials

Phase 1/2 Heart Defects, Congenital trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Phase 1/2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20081
20111
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine1
Boston Children's Hospital1
Carelon Research1
June Wu1
National Heart, Lung, and Blood Institute (NHLBI)1
University of Nebraska1
Vanderbilt University1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital8
Cardiovascular Diseases2
Heart Diseases2
Hypoplastic Left Heart Syndrome2
Chylothorax1
Hypertension, Pulmonary1
Inflammation1
Transposition of Great Vessels1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.